Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study.
about
Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease.The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.Sphingolipids in Alzheimer's Disease and Related Disorders.Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.
P2860
Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma Phospholipid and Sphing ...... ation Carriers: A Pilot Study.
@en
Plasma Phospholipid and Sphing ...... ation Carriers: A Pilot Study.
@nl
type
label
Plasma Phospholipid and Sphing ...... ation Carriers: A Pilot Study.
@en
Plasma Phospholipid and Sphing ...... ation Carriers: A Pilot Study.
@nl
prefLabel
Plasma Phospholipid and Sphing ...... ation Carriers: A Pilot Study.
@en
Plasma Phospholipid and Sphing ...... ation Carriers: A Pilot Study.
@nl
P2093
P2860
P50
P356
P1476
Plasma Phospholipid and Sphing ...... ation Carriers: A Pilot Study.
@en
P2093
Belinda M Brown
Chengjie Xiong
Guanghou Shui
Kevin Taddei
Marcus R Wenk
Ralph N Martins
Stuart G Snowden
Veer B Gupta
Wei L F Lim
P2860
P304
P356
10.3233/JAD-150948
P50
P577
2016-01-21T00:00:00Z